Abstract:Background Emerging evidence suggest the critical role of circular RNAs (circRNAs) in disease development especially in various cancers. However, the oncogenic role of circRNAs in hepatocellular carcinoma (HCC) is still largely unknown. Methods RNA sequencing was performed to identify significantly upregulated circRNAs in paired HCC tissues and non-tumor tissues. CCK-8 assay, colony formation, transwell, and xenograft mouse models were used to investigate the role of circRNAs in HCC proliferation and metastasis. Small interfering RNA (siRNA) was used to silence gene expression. RNA immunoprecipitation, biotin pull-down, RNA pull-down, luciferase reporter assay and western blot were used to explore the underlying molecular mechanisms. Results Hsa_circ_0095868 , derived from exon 5 of the MDK gene (named circMDK), was identified as a new oncogenic circRNA that was significantly upregulated in HCC. The upregulation of circMDK was associated with the modification of N6-methyladenosine (m 6 A) and poor survival in HCC patients. Mechanistically, circMDK sponged miR-346 and miR-874-3p to upregulate ATG16L1 (Autophagy Related 16 Like 1), resulting to the activation of PI3K/AKT/mTOR signaling pathway to promote cell proliferation, migration and invasion. Poly (β-amino esters) (PAEs) were synthesized to assist the delivery of circMDK siRNA (PAE-siRNA), which effectively inhibited tumor progression without obvious adverse effects in four liver tumor models including subcutaneous, metastatic, orthotopic and patient-derived xenograft (PDX) models. Conclusions CircMDK could serve as a potential tumor biomarker that promotes the progression of HCC via the miR-346/874-3p-ATG16L1 axis. The PAE-based delivery of siRNA improved the stability and efficiency of siRNA targeting circMDK. The PAE-siRNA nanoparticles effectively inhibited HCC proliferation and metastasis in vivo. Our current findings offer a promising nanotherapeutic strategy for the treatment of HCC. Graphical

The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas

A novel Circular RNA circRBMS3 promote malignant tumor growth and metastasis through miR-424-eIF4B/YRDC axis

A Novel Circular RNA Circrbms3 Regulates Proliferation and Metastasis of Osteosarcoma by Targeting Mir-424-eif4b/yrdc Axis

Dysregulated Circular RNAs in Medulloblastoma Regulate Proliferation and Growth of Tumor Cells Via Host Genes

Circ_103128 is Associated with the Tumorigenesis of Medulloblastoma.

miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4

Therapeutic SHPRH-146aa Encoded by Circ-Shprh Dynamically Upregulates P21 to Inhibit CDKs in Neuroblastoma

Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma

The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas

CircSKA3 Modulates FOXM1 to Facilitate Cell Proliferation, Migration, and Invasion While Confine Apoptosis in Medulloblastoma Via Mir-383-5p

CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

Circ_0021350 Plays an Oncogene Role by Regulating Mir-1207-3p/pik3r3 in Glioblastoma.

Circ_0001361/miR-490-5p/IGF2 Axis Regulates the Viability and Apoptosis of Neuroblastoma Cells.

Developmental basis of SHH medulloblastoma heterogeneity

Hsa_circ_0119412 Contributes to Development of Retinoblastoma by Targeting miR-186-5p/ELK4 Axis

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma

MEDU-37. CHOLESTEROL BIOSYNTHESIS REPRESENTS A NOVEL THERAPEUTIC TARGET FOR THE SONIC HEDGEHOG TYPE OF MEDULLOBLASTOMA

Circ_0079530 Stimulates THBS2 to Promote the Malignant Progression of Non-Small Cell Lung Cancer by Sponging Mir-584-5p.

Identification of Let-7 Mirna Activity As a Prognostic Biomarker of SHH Medulloblastoma

Research progress of Sonic Hedgehog signaling pathway and its targeted inhibitors in ;medulloblastoma